Diapocynin

Diapocynin

CAT N°: 14052
Price:

From 48.00 40.80

Diapocynin is the dimeric form of the NADPH oxidase inhibitor apocynin (Item No. 11976) that has anti-inflammatory and antioxidant activities. Diapocynin inhibits NADPH oxidase complex assembly and activation, gp91phox mRNA expression, and production of the pro-inflammatory cytokines TNF-? and IL-10 in peripheral blood mononuclear cells (PMBCs).{38084} It inhibits production of reactive oxygen species (ROS), calcium-independent isoform of phospholipase A2 (iPLA2) function, and reduces Ca2+ influx through store-operated and stretch-activated channels (SOCs and SACs, respectively) in dystrophic myotubes; all functions in the pathogenic cascade leading to muscular dystrophy.{38083} Diapocynin also reverses motor coordination deficits in the LRRK2R1441G mouse model of early Parkinson’s disease.{38082}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 1,1′-(6,6′-dihydroxy-5,5′-dimethoxy[1,1′-biphenyl]-3,3′-diyl)bis-ethanone
  • Correlated keywords
    • 1149749-29-0 dehydrodiacetovanillone antiinflammatory anti-oxidant PMBC iPLA-2 SOC SAC LRRK-2 TNF-a TNFa IL10 nicotinamide?adenine dinucleotide phosphate gp91-phox proinflammatory MD LRRK2-R1441G leucine-rich repate kinase NOX interleukin
  • Product Overview:
    Diapocynin is the dimeric form of the NADPH oxidase inhibitor apocynin (Item No. 11976) that has anti-inflammatory and antioxidant activities. Diapocynin inhibits NADPH oxidase complex assembly and activation, gp91phox mRNA expression, and production of the pro-inflammatory cytokines TNF-? and IL-10 in peripheral blood mononuclear cells (PMBCs).{38084} It inhibits production of reactive oxygen species (ROS), calcium-independent isoform of phospholipase A2 (iPLA2) function, and reduces Ca2+ influx through store-operated and stretch-activated channels (SOCs and SACs, respectively) in dystrophic myotubes; all functions in the pathogenic cascade leading to muscular dystrophy.{38083} Diapocynin also reverses motor coordination deficits in the LRRK2R1441G mouse model of early Parkinson’s disease.{38082}

We also advise you